Serum uric acid levels and longitudinal change in cognitive function in older adults: a sex-stratified population-based study
Open Access
- 30 December 2025
- journal article
- Published by Oxford University Press (OUP) in The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences
- Vol. 81 (3)
Abstract
Background: Serum uric acid (SUA) has been linked to cognitive function, but sex-specific associations remain unclear. Biological differences in SUA levels between sexes, driven by hormonal and renal factors, highlight the importance of sex-stratified analysis. This study examined the association between SUA levels and changes in cognitive function in older adults. Methods: A total of 11 411 community-dwelling ASPirin in Reducing Events in the Elderly participants, free from dementia at baseline and with valid SUA measurements, were included. The Modified Mini-Mental State Examination (3MS), Hopkins Verbal Learning Test–Revised (HVLT-R), Symbol Digit Modalities Test, and Controlled Oral Word Association Test were used to assess cognition at baseline and over a median follow-up of 9 years. Separate linear mixed-effects regression models in males and females were fitted to assess the associations between SUA levels and change in cognitive function over time. Results: Females in the lowest SUA quintile (Q1) had significant declines in the measure of global cognition (3MS: β ±SE= −0.07 ± 0.03, p = .02) and episodic memory (HVLT-R; delayed recall: β±SE= -0.03 ± 0.01, p = .02) compared to the middle quintiles (Q2-Q4), but the highest SUA quintile (Q5) was not associated with decline. No associations were observed for executive function, verbal fluency, or psychomotor speed. In males, no significant associations between SUA levels and change in cognitive function were observed. Conclusion: Low SUA levels were linked to decline in the measure of global cognition and episodic memory among females but not males. High SUA levels were not associated with cognitive decline. Managing SUA levels within the physiological range may support cognitive health, particularly in older females.Keywords
Funding Information
- National Institute on Aging and the National Cancer Institute at the National Institutes of Health (334047)
- National Institute on Aging and the National Cancer Institute at the National Institutes of Health (1127060)
- Joanne Ryan is supported by a National Health and Medical Research Council Research Leader Fellowship (1135727)
This publication has 53 references indexed in Scilit:
- Health Characteristics and Aspirin Use in Participants at the Baseline of the ASPirin in Reducing Events in the Elderly – eXTension (ASPREE-XT) Observational StudyContemporary Clinical Trials, 2023
- Association of plasma uric acid levels with cognitive function among non-hyperuricemia adults: A prospective studyClinical Nutrition, 2022
- 2021 Alzheimer's disease facts and figuresAlzheimer's & Dementia, 2021
- Uric acid and cardiovascular diseaseClinica Chimica Acta, 2018
- Higher baseline serum uric acid is associated with poorer cognition but not rates of cognitive decline in womenExperimental Gerontology, 2014
- Study design of ASPirin in Reducing Events in the Elderly (ASPREE): A randomized, controlled trialContemporary Clinical Trials, 2013
- Hearing Loss and Cognitive Decline in Older AdultsJAMA Internal Medicine, 2013
- Prevalence of gout and hyperuricemia in the US general population: The National Health and Nutrition Examination Survey 2007-2008Arthritis & Rheumatism, 2011
- Evaluating cognition in an elderly cohort via telephone assessmentInternational Journal of Geriatric Psychiatry, 2009
- Decreased plasma antioxidants in patients with Alzheimer's diseaseInternational Journal of Geriatric Psychiatry, 2006